The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Rates of nearsightedness, or myopia, are skyrocketing in kids—and scientists say it has to do with how little time they’re ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects millions but has no medical cure.

For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...

Dry eye, aggravated by cold weather, pollution, and extended screen time, causes significant discomfort and visual issues. Symptoms include redness, irritation, and blurred vision. Management ...

The iPhone vs Android debate is the real battle of the titans, at least when it comes to smartphones. So which is the true champ when it comes to mobile platforms? We have some insight on that ...

Tonabersat is under clinical development by Inflammx Therapeutics and currently in Phase II for Dry (Atrophic) Macular Degeneration. According to GlobalData, Phase II drugs for Dry (Atrophic) Macular ...

The research team from the Natural Product Drug Development Center at the Korea Institute of Science and Technology has developed a new therapeutic agent for dry Age-related macular degeneration that ...

Shelby Brown (she/her/hers) is an editor for CNET's services team. She covers tips and tricks for apps, operating systems and devices, as well as mobile gaming and Apple Arcade news. Shelby also ...

Age-related macular degeneration ... and distorted objects. Dry AMD accounts for 90% of all AMD cases, with relatively mild vision impairment; however, approximately 30% progress to the severe vision ...